Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-07-06 4:35 pm Purchase | 13D | REGENERX BIOPHARMACEUTICALS RGN | Essetifin SPA | 60,396,189 36.1% | 5,125,000 (+9.27%) | View |
| 2021-07-02 4:15 pm Purchase | 13D | REGENERX BIOPHARMACEUTICALS RGN | Essetifin SPA | 55,271,189 34.1% | 3,750,000 (+7.28%) | View |
| 2020-10-16 4:16 pm Purchase | 13D | REGENERX BIOPHARMACEUTICALS RGN | Essetifin SPA | 51,521,189 34.4% | 1,948,775 (+3.93%) | View |
| 2020-05-04 5:22 pm Purchase | 13D | FENNEC PHARMACEUTICALS, INC. O FENC | Essetifin SPA | 3,993,694 16.2% | 768,000 (+23.81%) | View |
| 2019-05-16 4:18 pm Purchase | 13D | REGENERX BIOPHARMACEUTICALS RGN | Essetifin SPA | 49,572,414 33.9% | 7,291,667 (+17.25%) | View |